{
    "2019-05-16": [
        [
            {
                "time": "2019-05-16",
                "original_text": "格隆汇港股聚焦(5.16)︱阿里健康年度经调整净利润增14倍至1.22亿元 天猫医药交易额达595亿元",
                "features": {
                    "keywords": [
                        "阿里健康",
                        "净利润",
                        "增长",
                        "天猫医药",
                        "交易额"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "电商"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "上海医药关于全资子公司获得药品GMP证书的公告",
                "features": {
                    "keywords": [
                        "上海医药",
                        "子公司",
                        "GMP证书"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "上海医药(02607)：上海一生化获得药品GMP证书",
                "features": {
                    "keywords": [
                        "上海医药",
                        "上海一生化",
                        "GMP证书"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019",
                "original_text": "上海医药(601607.SH)2019年股票期权激励计划获上海国资委批复",
                "features": {
                    "keywords": [
                        "上海医药",
                        "股票期权",
                        "激励计划",
                        "国资委批复"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "上海医药(02607.HK)全资子公司获药品GMP证书",
                "features": {
                    "keywords": [
                        "上海医药",
                        "子公司",
                        "GMP证书"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "复旦张江8成营收依赖前5大客户 销售费3.5亿为研发3倍",
                "features": {
                    "keywords": [
                        "复旦张江",
                        "营收",
                        "客户依赖",
                        "销售费用",
                        "研发投入"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}